Effects of growth-factor combinations on vascular endothelial cell growth in vitro

Wen-Chuan Wu1, Ying-Hsien Kao, Chia-Hung Chung

  • 1Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. wuoph@kmu.edu.tw

Insights

Diabetic retinopathy involves elevated growth factors. Insulin, IGF-I, and VEGF promote endothelial cell proliferation, while TGF-beta modulates these effects, highlighting its role in the condition.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Cell Biology

Background:

  • Diabetic retinopathy is linked to abnormal growth factor levels in ocular fluids and serum.
  • Understanding the role of specific growth factors in endothelial cell proliferation is crucial for diabetic retinopathy pathogenesis.

Purpose of the Study:

  • To investigate the individual and combined effects of insulin, IGF-I, VEGF, and TGF-beta on vascular endothelial cell proliferation.
  • To elucidate the complex regulatory role of TGF-beta in endothelial cell growth.

Main Methods:

  • Primary human umbilical vein endothelial cells (HUVECs) were utilized.
  • Cell proliferation was assessed using direct viable cell counting and proliferation assays.

Main Results:

  • Insulin, IGF-I, and VEGF demonstrated dose-dependent increases in endothelial cell number and proliferation.
  • TGF-beta significantly enhanced the stimulatory effects of insulin and VEGF on endothelial cell proliferation.
  • No synergistic effects were observed between TGF-beta and double or triple combinations of the other growth factors.

Conclusions:

  • TGF-beta plays a complex and significant role in regulating endothelial cell proliferation.
  • TGF-beta is implicated in the pathogenesis of diabetic retinopathy through its influence on endothelial cell growth.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...